RDNTライブシグナル | Getagraph.comで利益を最大化

売る 108133 min ago

@ $38.66

発行日: 14 2月 2024 @ 23:30

リターン: 27.72%

前回のシグナル: 2月 14 - 02:20

前回のシグナル: 買う

リターン: 1.74 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:41):

Stats
本日の出来高	129 150
平均出来高	552 390
時価総額	3.61B
EPS	$0.000550 ( 2024-03-01 )
次の収益日	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	987.50
ATR14	$0.0230 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Stolper Mark	Buy	14 072	Common Stock
2024-03-01	Stolper Mark	Buy	27 276	Employee Stock Option (right to buy)
2024-03-01	Patel Mital	Buy	15 422	Common Stock
2024-03-01	Patel Mital	Buy	29 891	Employee Stock Option (right to buy)
2024-03-01	Katz David Jeffrey	Buy	15 422	Common Stock

INSIDER POWER
74.00
Last 99 transactions
Buy: 1 387 551 \| Sell: 227 567

ボリューム相関

長: 0.11 (neutral)

短: -0.46 (neutral)

Signal:(64.115) Neutral

RadNet Inc 相関

10 最も正の相関
GAINL	0.892
SJ	0.868
BIOT	0.857
VRCA	0.857
MSAC	0.855
TZPS	0.854
AMTBB	0.853
LIBY	0.852
APOP	0.85
RMRM	0.848

10 最も負の相関
BOCH	-0.924
DRUG	-0.888
CMRX	-0.887
PRPH	-0.885
FSFG	-0.883
SHSP	-0.881
FRBK	-0.881
DAVE	-0.88
EBC	-0.879
BWB	-0.868

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

RadNet Inc 相関 - 通貨/商品

0.67
( moderate )

0.64
( weak )

0.00
( neutral )

0.72
( moderate )

0.55
( weak )

-0.84
( strong negative )

RadNet Inc 財務諸表

Annual	2023
収益:	$1.62B
総利益:	$93.00M (5.75 %)
EPS:	$0.0479

FY	2023
収益:	$1.62B
総利益:	$93.00M (5.75 %)
EPS:	$0.0479

FY	2022
収益:	$1.43B
総利益:	$165.72M (11.59 %)
EPS:	$0.600

FY	2021
収益:	$1.32B
総利益:	$191.80M (14.58 %)
EPS:	$0.470

Financial Reports:

No articles found.

RadNet Inc

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.